beta

CLPT

Clearpoint Neuro, Inc.

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Clearpoint Neuro, Inc. engages in the development and commercialization of innovative platforms for performing minimally invasive surgical procedures in the brain and heart. It conducts its procedures under direct, intra-procedural magnetic resonance imaging guidance. Its product platform is comprises of ClearPoint system and ClearTrace system. The company was founded by Paul A. Bottomley on March 12, 1998 and is headquartered in Irvine, CA.

Market Cap: 63.6 Million

Primary Exchange: NASDAQ

Website: http://www.clearpointneuro.com

Shares Outstanding: 15.5 Million

Float: 11.4 Million

Dividend: (%)

Beta: 0.7599994759475

Sector: Health Technology

Industry: Medical Specialties

Ethical Flags

Longest drawdown: 70 trading days

From: 2020-02-13 To: 2020-05-22

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud